Published in Pharmacotherapy on October 09, 1986
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis (2011) 2.32
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
GC-MS analysis of bioactive compounds in the methanol extract of Clerodendrum viscosum leaves. Pharmacognosy Res (2015) 0.97
Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait. Am J Hum Genet (2000) 0.96
A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg (2013) 0.89
Enzymes of glycerol and glyceraldehyde metabolism in mouse liver: effects of caloric restriction and age on activities. Biosci Rep (2008) 0.87
Glycerol extends lifespan of Brachionus manjavacas (Rotifera) and protects against stressors. Exp Gerontol (2014) 0.83
Investigation of intravascular haemolysis during treatment of acute stroke with intravenous glycerol. Br J Clin Pharmacol (1990) 0.75
Exploring Lactobacillus reuteri DSM20016 as a biocatalyst for transformation of longer chain 1,2-diols: Limits with microcompartment. PLoS One (2017) 0.75
The effect of AQP3 deficiency on fuel selection during a single bout of exhausting exercise. Pflugers Arch (2016) 0.75
Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol (2001) 2.42
Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf (2000) 2.37
Efficacy of diazepam and meperidine in ambulatory pediatric patients undergoing endoscopy: a randomized, double-blind trial. J Pediatr Gastroenterol Nutr (1993) 2.19
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother (1992) 2.13
Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr (2000) 1.81
Once-daily administration of aminoglycosides. Ann Pharmacother (1994) 1.73
Differential absorption of amoxicillin from the human small and large intestine. Clin Pharmacol Ther (1994) 1.68
Teaching paediatric pharmacotherapy at colleges of pharmacy in the United States and Canada. J Clin Pharm Ther (1994) 1.48
Issues facing clinical pharmacy education for undergraduate students. DICP (1989) 1.40
Role of the ketogenic diet in children with intractable seizures. Ann Pharmacother (1998) 1.39
Standard room temperature needed for stability and compatibility studies. Am J Hosp Pharm (1993) 1.39
Healing of perineal Crohn's disease with metronidazole. Gastroenterology (1980) 1.37
Treatment of listeriosis. Ann Pharmacother (2000) 1.32
Need for conducting research on medications unlabeled for use in pediatric patients. Ann Pharmacother (1994) 1.30
Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology (1982) 1.26
Clinical use of systemic antifungal agents. Clin Pharm (1988) 1.23
Clinical pharmacokinetics of antibacterial drugs in neonates. Clin Pharmacokinet (1990) 1.21
California encephalitis in children. Am J Dis Child (1972) 1.20
Oxacillin-tolerant staphylococcal bacteremia in children. J Pediatr (1980) 1.20
CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. AJR Am J Roentgenol (1994) 1.18
Chloramphenicol serum concentration falls during chloramphenicol succinate dosing. Clin Pharmacol Ther (1983) 1.16
Symptomatic sarcoidosis of the stomach. Dig Dis Sci (1985) 1.14
Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother (1999) 1.09
Pharmacokinetics of amphotericin B in children. Antimicrob Agents Chemother (1989) 1.07
Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants. Eur J Clin Pharmacol (1988) 1.05
Survival following myocarditis and myocardial calcification associated with infection by Coxsackie virus B-4. Pediatrics (1981) 1.03
Complication of intranasal midazolam. Pediatrics (1993) 1.03
Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm (1987) 1.03
Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Ther Drug Monit (1987) 1.02
Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. AJR Am J Roentgenol (1994) 1.01
Rapid and accurate diagnosis of acute cholecystitis with 99mTc-HIDA cholescintigraphy. AJR Am J Roentgenol (1979) 1.01
Healing of perineal Crohn's disease with metronidazole. Gastroenterology (1980) 1.00
Pathogenesis and treatment of bronchiolitis. Clin Pharm (1993) 0.99
Reye's syndrome and hyperaminoacidemia. J Pediatr (1974) 0.98
Role of 99mTc-IDA cholescintigraphy in evaluating biliary tract disorders. Gastrointest Radiol (1980) 0.97
Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics (1998) 0.97
Antibiotic management of complicated appendicitis. J Pediatr Surg (1983) 0.96
Nelfinavir mesylate: a protease inhibitor. Ann Pharmacother (1999) 0.96
Cephalexin: treatment of streptococcal pharyngitis. J Pediatr (1972) 0.96
A new method for computed tomography image compression using adjacent slice data. Invest Radiol (1993) 0.96
A comparative review of conventional and lipid formulations of amphotericin B. J Clin Pharm Ther (1999) 0.95
Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Chemotherapy (1987) 0.95
Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol (1984) 0.95
Variation in morphine pharmacokinetics in children with cancer. Dev Pharmacol Ther (1985) 0.95
Adverse effects of meperidine, promethazine, and chlorpromazine for sedation in pediatric patients. Clin Pediatr (Phila) (1985) 0.94
Picornaviruses: rapid differentiation and identification by immune electronmicroscopy and immunodiffusion. J Med Microbiol (1977) 0.94
Antimicrobial dosages in guidelines for prevention of bacterial endocarditis. Clin Pharm (1991) 0.94
Effect of gestational age and birth weight on tobramycin kinetics in newborn infants. J Antimicrob Chemother (1984) 0.94
Determination of cefaclor by high-performance liquid chromatography. J Chromatogr (1982) 0.94
Pharmacokinetics of dexamethasone in premature neonates. Eur J Clin Pharmacol (1996) 0.93
Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J Clin Pharm Ther (1989) 0.93
Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction. DICP (1989) 0.93
Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol (1999) 0.92
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother (1995) 0.92
How should radiologists reply when patients ask about their diagnoses? A survey of radiologists' and clinicians' preferences. AJR Am J Roentgenol (1993) 0.92
Effect of infusion methods on tobramycin serum concentrations in newborn infants. J Pediatr (1984) 0.91
Pharmacokinetics of cefuroxime axetil suspension in infants and children. Antimicrob Agents Chemother (1991) 0.91
An on-line digital Internet radiology teaching file server. AJR Am J Roentgenol (1994) 0.90
Metastatic calcification of the heart and lungs in end-stage renal disease: detection and quantification by dual-energy digital chest radiography. AJR Am J Roentgenol (1987) 0.90
Severe lower intestinal bleeding: diagnosis and treatment. Clin Gastroenterol (1981) 0.90
Oral terbinafine: a new antifungal agent. Ann Pharmacother (1997) 0.90
Delivery of tobramycin by three infusion systems. Chemotherapy (1984) 0.89
Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Pediatr Pulmonol (2001) 0.89
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis. Chest (1997) 0.89
Small-airway diseases of the lungs: findings at expiratory CT. AJR Am J Roentgenol (1994) 0.89
Treatment of a patient with watermelon stomach using transendoscopic laser photocoagulation. Gastrointest Endosc (1988) 0.89
Pharmacokinetics of netilmicin in premature infants. Eur J Clin Pharmacol (1986) 0.88
Research productivity and funding. DICP (1991) 0.87
Bacterial contamination of aerosol solutions used to treat cystic fibrosis. Am J Hosp Pharm (1982) 0.87
Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate. Clin Pharmacol Ther (1981) 0.87
Bone scan patterns in acute osteomyelitis. Clin Orthop Relat Res (1981) 0.87
Serendipity in technetium-99m dimethyl iminodiacetic acid cholescintigraphy: diagnosis of nonbiliary disorders in suspected acute cholecystitis. Radiology (1980) 0.86
CT mosaic pattern of lung attenuation: distinguishing different causes. AJR Am J Roentgenol (1995) 0.86
Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination. Drug Intell Clin Pharm (1988) 0.85
Treatment of irritable bowel syndrome. J Clin Pharm Ther (2010) 0.85
Pharmacokinetics of phenytoin in children with acute neurotrauma. Crit Care Med (1995) 0.85
Effect of ascorbic acid on urine pH in man. Am J Hosp Pharm (1977) 0.84
Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. Otolaryngol Head Neck Surg (1997) 0.84
Interlot variability in gentamicin and tobramycin concentration and its possible significance. Ther Drug Monit (1986) 0.84
Clinical uses of fentanyl, sufentanil, and alfentanil. Clin Pharm (1991) 0.84
Identification of long chain dicarboxylic acids in the serum of two patients with Reye's syndrome. J Chromatogr (1983) 0.83
ECHO virus type 3 infections in children: clinical and laboratory studies. J Pediatr (1972) 0.83
Chronic suppurative otitis media. Ann Pharmacother (1994) 0.83
Pharmacologic management of patent ductus arteriosus. Clin Pharm (1989) 0.83
Treatment of pediatric hypertension. Pharmacotherapy (2000) 0.83
Moxalactam epimer kinetics in children. Clin Pharmacol Ther (1982) 0.82
Gastrostomy tube placement in nonadherent HIV-infected children. Ann Pharmacother (2001) 0.82
Cephalexin pharmacokinetics in patients with cystic fibrosis. Dev Pharmacol Ther (1984) 0.82
Tobramycin pharmacokinetics in very low birth weight infants. Br J Clin Pharmacol (1986) 0.82
Periorbital cellulitis secondary to Conidiobolus incongruus. Pharmacotherapy (2001) 0.82
Interactions among chloramphenicol, phenytoin, and phenobarbital in a pediatric patient. J Pediatr (1981) 0.82
Dopamine and dobutamine in pediatric therapy. Pharmacotherapy (1989) 0.82
The safety and antiviral effect of protease inhibitors in children. Pharmacotherapy (2001) 0.81
Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy (1990) 0.81
Tobramycin kinetics in newborn infants. J Pediatr (1983) 0.81
Effect of intravenous flow rate and injection site on in vitro delivery of chloramphenicol succinate and in vivo kinetics. J Pediatr (1981) 0.81
Response to initial griseofulvin therapy in pediatric patients with tinea capitis. Ann Pharmacother (1997) 0.80
Clinical use of fluoroquinolones in children. Ann Pharmacother (2000) 0.80